FY25 Q3 trading update
Listen to our FY25 Q3 trading update, which took place on 27th January 2025 at 09:00 GMT.
![Investors_WhyInvest.png](https://www.drmartensplc.com/application/files/4916/0994/0252/Investors_WhyInvest_v2.png)
Why invest
We have a number of competitive strengths which act as differentiators and position the business for growth.
>60
years of heritage
61%
Revenue from DTC
£877.1m
Revenue
7%
Average Annual Revenue Growth Since FY201
11.5
million pairs sold
60+
countries operated in
£197.5m
EBITDA
22.5%
EBITDA margin
Source: DM Audited Accounts, Company data.
Note: March financial year end. All figures are FY24, unless otherwise specified.
1. FY20 - FY24 CAGR